$5.13
0.39%
Nasdaq, Aug 22, 10:00 pm CET
ISIN
US65343E1082
Symbol
NXTC

NextCure, Inc. Stock price

$5.13
+0.21 4.27% 1M
-3.87 43.00% 6M
-4.12 44.55% YTD
-13.83 72.94% 1Y
-48.99 90.52% 3Y
-101.79 95.20% 5Y
-174.87 97.15% 10Y
-174.87 97.15% 20Y
Nasdaq, Closing price Fri, Aug 22 2025
+0.02 0.39%
ISIN
US65343E1082
Symbol
NXTC
Industry

Key metrics

Basic
Market capitalization
$13.7m
Enterprise Value
$-21.6m
Net debt
positive
Cash
$35.3m
Shares outstanding
2.3m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
- | -
EV/Sales
- | -
EV/FCF
0.4
P/B
0.4
Financial Health
Equity Ratio
81.0%
Return on Equity
-85.5%
ROCE
-171.3%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$0.0 | $0.0
EBITDA
$-62.0m | -
EBIT
$-63.2m | $-48.5m
Net Income
$-60.9m | $-42.6m
Free Cash Flow
$-54.5m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
0.3% | -
EBIT
3.3% | 15.7%
Net Income
-0.3% | 24.0%
Free Cash Flow
-18.3%
Margin (TTM | estimate)
Gross
-
EBITDA
- | -
EBIT
-
Net
- | -
Free Cash Flow
-
More
EPS
$-307.9
FCF per Share
$-23.3
Short interest
3.4%
Employees
43
Rev per Employee
$0.0
Show more

Is NextCure, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,019 stocks worldwide.

NextCure, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a NextCure, Inc. forecast:

7x Buy
78%
2x Hold
22%

Analyst Opinions

9 Analysts have issued a NextCure, Inc. forecast:

Buy
78%
Hold
22%

Financial data from NextCure, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 14 14
16% 16%
-
- Research and Development Expense 48 48
4% 4%
-
-62 -62
0% 0%
-
- Depreciation and Amortization 1.25 1.25
62% 62%
-
EBIT (Operating Income) EBIT -63 -63
3% 3%
-
Net Profit -61 -61
0% 0%
-

In millions USD.

Don't miss a Thing! We will send you all news about NextCure, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

NextCure, Inc. Stock News

Neutral
The Motley Fool
17 days ago
NextCure (NXTC) Q2 Loss Widens 71%
Neutral
GlobeNewsWire
18 days ago
BELTSVILLE, Md., Aug. 07, 2025 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class, and best-in-class therapies to treat cancer, today provided a business update and reported second quarter 2025 financial results.
Neutral
GlobeNewsWire
about one month ago
BELTSVILLE, Md., July 24, 2025 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class and best-in-class therapies to treat cancer, today announced the presentation of new preclinical data in a well-established model of osteogenesis imperfecta (OI) demonstrating that treatment with NC605, a novel...
More NextCure, Inc. News

Company Profile

NextCure, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing immunomedicines to treat cancer and other immune-related diseases. Its novel FIND-IO discovery technology identifies targets based on immunomodulatory function and on which the company is building a proprietary pipeline of immunomedicines. The company was founded by Michael S. Richman and Lie Ping Chen in September 2015 and is headquartered in Beltsville, MD.

Head office United States
CEO Michael Richman
Employees 43
Founded 2015
Website www.nextcure.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today